Asston Pharmaceu

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0SJX01015
  • NSEID:
  • BSEID: 544445
INR
113.40
0.00 (0.00%)
BSENSE

Sep 01, 03:30 PM

BSE+NSE Vol: 136000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 10039662,
    "name": "Asston Pharmaceu",
    "stock_name": "Asston Pharmaceu",
    "full_name": "Asston Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/asston-pharmaceu",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "113.40",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "113.40",
    "mcapval": "107.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 544445,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE0SJX01015",
    "curr_date": "Sep 01, 03:30 PM",
    "curr_time": "09:10 AM",
    "last_traded_at": "Sep 01, 03:30 PM IST",
    "bse_nse_vol": 136000,
    "exc_status": "Active",
    "traded_date": "Sep 01, 2026",
    "traded_date_str": "2026 09 01",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/asston-pharmaceu-10039662-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 7,
    "sid": "10039662",
    "stock_news_url": "https://www.marketsmojo.com/news/asston-pharmaceuticals-10039662"
  },
  "announcements": [
    {
      "caption": "Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011",
      "datetime": "31-Aug-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Prakruti R Pali",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Convening 7Th Annual General Meeting Of The Company",
      "datetime": "27-Aug-2026",
      "details": "Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/09/2026 inter alia to consider and approve 1. Appointment of M/s Panchal S K & Associates (Peer Review Certificate No.: 018089 and Firm Registration No.: 145989W) as Statutory Auditor of the Company;",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "03-Aug-2026",
      "details": "Voting Result and Scrutinizer report for EGM held on 31st July 2026 through VC-OAVM",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "04 Sep 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011

31-Aug-2026 | Source : BSE

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Prakruti R Pali

Board Meeting Intimation for Convening 7Th Annual General Meeting Of The Company

27-Aug-2026 | Source : BSE

Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/09/2026 inter alia to consider and approve 1. Appointment of M/s Panchal S K & Associates (Peer Review Certificate No.: 018089 and Firm Registration No.: 145989W) as Statutory Auditor of the Company;

Shareholder Meeting / Postal Ballot-Scrutinizers Report

03-Aug-2026 | Source : BSE

Voting Result and Scrutinizer report for EGM held on 31st July 2026 through VC-OAVM

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

04 Sep 2026

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available